What were Blue Jet Healthcare Ltd's latest quarterly results?
Blue Jet Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -59.6%
- Revenue Growth YoY: -39.6%
- Operating Margin: 24.0%
Blue Jet Healthcare Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 20.3. ROE: 30.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Blue Jet Healthcare Ltd's latest quarterly results (Dec 2025) show
Blue Jet Healthcare Ltd's current PE ratio is 20.3x.
Blue Jet Healthcare Ltd's price-to-book ratio is 4.8x.
Blue Jet Healthcare Ltd's fundamental strength based on key financial ratios
Blue Jet Healthcare Ltd has a debt-to-equity ratio of N/A.
Blue Jet Healthcare Ltd's return ratios over recent years
Blue Jet Healthcare Ltd's operating cash flow is positive (FY2025).
Blue Jet Healthcare Ltd's current dividend yield is 0.35%.
Blue Jet Healthcare Ltd's shareholding pattern (Dec 2025)
Blue Jet Healthcare Ltd's promoter holding has remained stable recently.
Blue Jet Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Blue Jet Healthcare Ltd may be worth studying
Blue Jet Healthcare Ltd investment thesis summary:
Blue Jet Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.